Virtual Retail Pharmacy: Can You Survive Amazon’s Disruption to the Traditional Pharmacy Structure?
Independent and specialty pharmacies have always had their share of obstacles in the industry. Over the past few years, hurdles such as pharmacy benefit managers (PBMs), smaller, more-focused markets, short shelf lives, and maintaining a healthy, strong drug supply...
NASP: Calling Out DIR Fees and PBM Complicity
The National Association of Specialty Pharmacy (NASP) made a bold and decisive move by stating its position on specialty drug pricing’s two most controversial issues – DIR Fees and PBM Complicity. The NASP believes that the lack of transparency in assessing these fees...
Any Willing Provider Laws: Can You Keep Your Patients from Going to Larger Chain Stores?
Have you had healthcare plans calling or sending letters to your customers informing them that they must get their prescriptions filled at a larger chain store? Are they calling your pharmacy? Some may find this practice alarming but, surprisingly, it isn’t a new...
DIR Fees and the Importance of Alliances to Drive Transparency and Save Costs
There are many unique challenges to running profitable independent pharmacies. One challenge that can have a negative impact is an independent pharmacy’s dealings with pharmacy benefit managers (PBMs). Unlike larger retail pharmacies, which have a broader inventory of...